ArticleFrontiers in aging neuroscience2026
Optical coherence tomography artefact burden predicts cognitive decline and incident dementia.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Scalable, low-burden biomarkers for predicting cognitive decline remain needed. We hypothesised that OCT acquisition irregularities (commonly termed scan artefacts), which may reflect visuomotor and attentional instability during imaging, carry prognostic information for cognitive outcomes. Methods: We studied 507 Asian memory clinic participants who underwent baseline OCT imaging and comprehensive neuropsychological assessment annually for up to 5 years. OCT artefacts (motion, shadow, off-centre, refractive shift, out-of-boundary, and tilt) and signal strength were graded at baseline. Clinically significant cognitive decline was defined as a ≥ 0.5 standard deviation decrease in global cognitive z-score from baseline at any follow-up visit. Cox proportional hazards models evaluated associations between artefact burden and incident cognitive decline, adjusting for demographics, education, diabetes, and baseline cognitive status/diagnosis. Among participants with cognitive impairment no dementia (CIND) at baseline ( Results: Cognitive decline occurred in 289 participants (57%). Presence of any artefact was associated with higher risk of decline (HR = 1.37, 95% CI = 1.12-1.68, Conclusion: Routine OCT acquisition irregularities may provide an opportunistic, low-burden prognostic signal for cognitive vulnerability and dementia progression, complementing established neurodegenerative biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.